Baker McKenzie advised Olink Holding AB (publ), a leader in next generation proteomics (NASDAQ: OLK) in its sale to Thermo Fisher Scientific (NYSE: TMO) in an all-cash transaction valued at approximately $3.1 billion (including net cash).
Co-led by partners Mark Mandel and Henric Roth together with Piotr Korzynski and Carl Svernlöv, the Baker McKenzie team includes:
• M&A/Capital Markets: Mark Mandel, Piotr Korzynski, Justin Bryant, Roger Bivans, Gwen Karanadze, Adam Buehler, Sarah Rodrigue, Lewis Assness, Shelly Kuo, Adeola Alade, Zach Bassen, Rachel Gray, Franchesca Alamo
• Stockholm M&A/Capital Markets: Henric Roth, Carl Svernlöv, Per Blom, Monica Ericson
• Antitrust: John Fedele, Heidi Smucker
• Benefits: Thomas Asmar, Sesen Hailemichael
• Foreign Investment: Rod Hunter, Alexandra Kumar
• Employment: Elizabeth Ebersole, Adeola Olowude, Amanda Cohen
• Stockholm Employment: Ida Cederborg and Amanda Thieme
• Environment: Jessica Wicha
• Intellectual Property: Adam Aft, Robby Turner
• International Commercial: Sylwia Lis, Lise Test,
• Real Estate: Sarah Winston, Sarah Swain, Amanda Jaramillo
• Tax: Kai Kramer, Ross Staine, Joseph Chung
• Stockholm Tax: Linnea Back, Ulrika Udén, Oskar Salenstedt
• Litigation: Peter Tomczak, Matthew Allison, Geoff Martin, Xin Tao
In addition, lawyers from Baker McKenzie's offices in Belgium, Canada, China, France, Germany, Italy, Japan, the Netherlands, Switzerland and the United Kingdom formed part of Baker McKenzie's wider transaction team.
Located in financial centers and emerging markets, Baker McKenzie is a transactional powerhouse with more than 2,500 deal practitioners offering leading counsel in the areas most critical for our clients. Its lawyers excel in complex transactions and cross-border deals – over 65% of their deals are multi-jurisdictional. The seasoned transactional team provides seamless counsel through local excellence, deep sector knowledge, commercial acumen and refined transactional techniques to maximize deal certainty and deliver maximum value to clients.
As one of the first law firms to advise life sciences corporates on their global expansion 60 years ago, Baker McKenzie's knowledge is rooted in its DNA, with more than 800 dedicated lawyers focused on the industry in more than 45 jurisdictions, including the 10 largest life sciences markets globally.
Co-led by partners Mark Mandel and Henric Roth together with Piotr Korzynski and Carl Svernlöv, the Baker McKenzie team includes:
• M&A/Capital Markets: Mark Mandel, Piotr Korzynski, Justin Bryant, Roger Bivans, Gwen Karanadze, Adam Buehler, Sarah Rodrigue, Lewis Assness, Shelly Kuo, Adeola Alade, Zach Bassen, Rachel Gray, Franchesca Alamo
• Stockholm M&A/Capital Markets: Henric Roth, Carl Svernlöv, Per Blom, Monica Ericson
• Antitrust: John Fedele, Heidi Smucker
• Benefits: Thomas Asmar, Sesen Hailemichael
• Foreign Investment: Rod Hunter, Alexandra Kumar
• Employment: Elizabeth Ebersole, Adeola Olowude, Amanda Cohen
• Stockholm Employment: Ida Cederborg and Amanda Thieme
• Environment: Jessica Wicha
• Intellectual Property: Adam Aft, Robby Turner
• International Commercial: Sylwia Lis, Lise Test,
• Real Estate: Sarah Winston, Sarah Swain, Amanda Jaramillo
• Tax: Kai Kramer, Ross Staine, Joseph Chung
• Stockholm Tax: Linnea Back, Ulrika Udén, Oskar Salenstedt
• Litigation: Peter Tomczak, Matthew Allison, Geoff Martin, Xin Tao
In addition, lawyers from Baker McKenzie's offices in Belgium, Canada, China, France, Germany, Italy, Japan, the Netherlands, Switzerland and the United Kingdom formed part of Baker McKenzie's wider transaction team.
Located in financial centers and emerging markets, Baker McKenzie is a transactional powerhouse with more than 2,500 deal practitioners offering leading counsel in the areas most critical for our clients. Its lawyers excel in complex transactions and cross-border deals – over 65% of their deals are multi-jurisdictional. The seasoned transactional team provides seamless counsel through local excellence, deep sector knowledge, commercial acumen and refined transactional techniques to maximize deal certainty and deliver maximum value to clients.
As one of the first law firms to advise life sciences corporates on their global expansion 60 years ago, Baker McKenzie's knowledge is rooted in its DNA, with more than 800 dedicated lawyers focused on the industry in more than 45 jurisdictions, including the 10 largest life sciences markets globally.
Explore Our Newsroom